ArticleBone marrow transplantation2021

Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.

Klaus Hirschbühl et al.PubMed ↗Publisher ↗

No numbers read from the abstract.